Detalhe da pesquisa
1.
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study.
Lancet Infect Dis
; 22(6): 879-890, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247321